These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

795 related items for PubMed ID: 27281609

  • 1. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N.
    Oncotarget; 2016 Jul 12; 7(28):43124-43149. PubMed ID: 27281609
    [Abstract] [Full Text] [Related]

  • 2. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.
    Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969
    [Abstract] [Full Text] [Related]

  • 3. Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
    Dey N, Young B, Abramovitz M, Bouzyk M, Barwick B, De P, Leyland-Jones B.
    PLoS One; 2013 Jan 10; 8(10):e77425. PubMed ID: 24143235
    [Abstract] [Full Text] [Related]

  • 4. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N, Barwick BG, Moreno CS, Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C, Kerstann KF, Sledge GW, Abramovitz M, Bouzyk M, De P, Leyland-Jones BR.
    BMC Cancer; 2013 Nov 10; 13():537. PubMed ID: 24209998
    [Abstract] [Full Text] [Related]

  • 5. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
    Tzeng HE, Yang L, Chen K, Wang Y, Liu YR, Pan SL, Gaur S, Hu S, Yen Y.
    Oncotarget; 2015 May 10; 6(13):11061-73. PubMed ID: 25857298
    [Abstract] [Full Text] [Related]

  • 6. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT.
    Nie J, Jiang HC, Zhou YC, Jiang B, He WJ, Wang YF, Dong J.
    Biosci Biotechnol Biochem; 2019 Jun 10; 83(6):1062-1071. PubMed ID: 30950326
    [Abstract] [Full Text] [Related]

  • 7. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.
    Liu L, Yu D, Shi H, Li J, Meng L.
    Pharmazie; 2017 Oct 01; 72(10):599-603. PubMed ID: 29441885
    [Abstract] [Full Text] [Related]

  • 8. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
    Giacomelli C, Jung J, Wachter A, Ibing S, Will R, Uhlmann S, Mannsperger H, Sahin Ö, Yarden Y, Beißbarth T, Korf U, Körner C, Wiemann S.
    BMC Cancer; 2021 Dec 04; 21(1):1296. PubMed ID: 34863149
    [Abstract] [Full Text] [Related]

  • 9. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J, Xu HD, Xing XJ, Liang ZT, Xia ZH, Zhao Y.
    Eur Rev Med Pharmacol Sci; 2019 Jun 04; 23(12):5315-5322. PubMed ID: 31298383
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt/β-catenin signaling.
    Peng J, Liu X, Mao Y, Lv M, Ma T, Liu J, Zhou Q, Han Y, Li X, Wang H.
    Mol Carcinog; 2024 Aug 04; 63(8):1588-1598. PubMed ID: 38780151
    [Abstract] [Full Text] [Related]

  • 11. Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.
    Renner G, Noulet F, Mercier MC, Choulier L, Etienne-Selloum N, Gies JP, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M.
    Oncotarget; 2016 Sep 20; 7(38):62194-62207. PubMed ID: 27613837
    [Abstract] [Full Text] [Related]

  • 12. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling.
    Yu L, Wang C, Pan F, Liu Y, Ren X, Zeng H, Shi Y.
    Biomed Pharmacother; 2019 Oct 20; 118():109361. PubMed ID: 31545274
    [Abstract] [Full Text] [Related]

  • 13. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 14. Cadmium stimulates metastasis-associated phenotype in triple-negative breast cancer cells through integrin and β-catenin signaling.
    Wei Z, Shaikh ZA.
    Toxicol Appl Pharmacol; 2017 Aug 01; 328():70-80. PubMed ID: 28527916
    [Abstract] [Full Text] [Related]

  • 15. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
    Klemm F, Bleckmann A, Siam L, Chuang HN, Rietkötter E, Behme D, Schulz M, Schaffrinski M, Schindler S, Trümper L, Kramer F, Beissbarth T, Stadelmann C, Binder C, Pukrop T.
    Carcinogenesis; 2011 Mar 01; 32(3):434-42. PubMed ID: 21173432
    [Abstract] [Full Text] [Related]

  • 16. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H, Wang Y, Xue F.
    Oncol Rep; 2013 Feb 01; 29(2):507-14. PubMed ID: 23135473
    [Abstract] [Full Text] [Related]

  • 17. Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis.
    Wang Z, Li Y, Xiao Y, Lin HP, Yang P, Humphries B, Gao T, Yang C.
    Int J Cancer; 2019 Nov 15; 145(10):2767-2780. PubMed ID: 31008533
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP, Mirza S, Sharma G, Prashad R, DattaGupta S, Rath G, Ralhan R.
    Life Sci; 2008 Aug 29; 83(9-10):318-25. PubMed ID: 18662704
    [Abstract] [Full Text] [Related]

  • 19. Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway.
    Lan K, Zhao Y, Fan Y, Ma B, Yang S, Liu Q, Linghu H, Wang H.
    Int J Mol Sci; 2017 Apr 27; 18(5):. PubMed ID: 28448437
    [Abstract] [Full Text] [Related]

  • 20. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
    Moroney MR, Woodruff E, Qamar L, Bradford AP, Wolsky R, Bitler BG, Corr BR.
    Mol Carcinog; 2021 Aug 27; 60(8):511-523. PubMed ID: 34038589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.